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Abstract 
trans-4-Acylamino-2-(polyfluoroalkyl)chromans were synthesized using a Ritter reaction 
between cis-2-(polyfluoroalkyl)chroman-4-ols and various nitriles.  
 
Keywords: 2-(Polyfluoroalkyl)chromans, reduction, oxidation, dehydration, Ritter reaction  
 
 
 
Introduction 
 
The biological activity of many of the naturally occurring compounds which incorporate a 
chroman ring system has resulted in several applications of chromans of various levels of 
saturation and oxidation in synthesis.1 Furthermore, they have considerable biological 
importance, especially as potentially useful pesticides2 and drug candidates in the field of 
potassium channel openers.3 On the other hand, the polyfluoroalkyl groups are highly important 
substituents in the field of organic chemistry. The introduction of these groups into organic 
molecules can bring about some remarkable changes in the physical properties, chemical 
reactivity, and biological activity of the derived fluorinated compounds.4 In particular, due to the 
powerful electron-withdrawing ability of polyfluoroalkyl substituents 2-RF-chromones,5 3-
RFCO-chromones6 and 3-nitro-2-RF-chromenes7 have attracted our attention as highly reactive 
compounds, which can serve as the starting substances in the synthesis of a whole series of 
heterocycles with interesting properties.  
However, to the best of our knowledge, very little is known about the synthesis and 
properties of partially fluorinated chroman derivatives. We have recently shown that the reaction 
of 2-RF-chromones with CF3SiMe3 proceeded as a 1,4-addition and provided an access to 2,2-
bis(polyfluoroalkyl)chroman-4-ones and their derivatives.8 Earlier 2,2-bis(trifluoromethyl)-6-
nitrochroman-4-one, which is a key structural element of the fluorinated analogues of an 
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important class of potassium channel openers, benzopyran-4-amide derivatives, was prepared by 
treating 2-fluoro-5-nitroacetophenone with hexafluoroacetone trihydrate.9 Also, 2,2,6-
tris(trifluoromethyl)-2H-chromene, a key intermediate for the preparation of the fluorinated 
analogues of cromakalim, a highly potent antihypertensive drug,10 and 6,7-dimethoxy-2-methyl-
2-(trifluoromethyl)-2H-chromene, a trifluoromethyl analogue of the natural insect antijuvenile 
hormone precocene II,11 were described. There has been only one paper on the synthesis of 
chroman-4-one with a trifluoromethyl group at the 2 position.12 In view of the unique biological 
properties displayed by chromans13 on one hand and by many CF3-containing heterocycles4 on 
the other hand, it was of interest to obtain novel fluorine-containing chroman derivatives from 2-
RF-chromones.  
 
 
Results and Discussion 
 
Chromones and chromanones can be reduced with different reagents but also undergo ring 
opening, hydrogenolysis and other side reactions which lower the yields of chroman-4-ols.14 
Attempted reduction of chromones using hydride donors such as NaBH4 or hydrogenation using 
noble metal catalysts has been reported to lead to complex mixtures from over-reduction.15 We 
found that 2-RF-chromones 1a–c smoothly reacted with sodium borohydride in methanol to 
afford cis-2-(polyfluoroalkyl)chroman-4-ols 2a–c in good yields (65–83%). The corresponding 
chromanone 3, intermediate of the reaction, is in situ reduced to chromanol 2 because the 
reduction of 3 is faster than that of 1 due to double bond conjugation in the latter. Reduction of 1 
to 2 exhibits high stereoselectivity and the cis-structure of chromanols 2 is evident from the 
coupling constants. In the 1H NMR spectra, the axial H-3 proton manifests itself at δ 2.03–2.10 
as a doublet of triplets or a doublet of doublets of doublets with the geminal constant 2J = 12.8–
13.4 Hz and the vicinal constants 3JH3,H2 = 9.9–12.1 Hz and 3JH3,H4 = 8.9–10.8 Hz, which indicate 
the axial arrangement of the H-2 and H-4 atoms. Therefore, chromanols 2 in CDCl3 are in the 
half-chair conformation with cis-diequatorial arrangement of the substituents. Initial attack at the 
carbonyl group of 3 by sodium borohydride might be expected to occur from the side opposite to 
the RF group leading to the cis-2. Note that reduction of flavones and chromones with 
NaBH4/NiCl2 in methanol also yields cis-flavan-4-ols and cis-chroman-4-ols.14  
Selective reduction of the double bond in chromone 1a can be achieved by using of 
diisobutylaluminium hydride (1 equiv.) in THF–toluene solution at –78 oC. In this case, 
chroman-4-one 3a was obtained as a sole product in 56% yield. This is not surprising since 
reduction of isoflavones to isoflavan-4-ones under the same reaction conditions has been 
described previously.16 In addition, homoisoflavones has been converted into homoisoflavanones 
by subjecting to catalytic hydrogenation.17 The oxidation of chromanols 2a,b to chromanones 
3a,b in 74–79% yields was performed with chromic acid (from sodium dichromate and sulfuric 
acid) in ethyl ether.18 Dehydration of chromanol 2a was effected by a trace of p-toluene sulfonic 
ISSN 1551-7012 Page 126 ©ARKAT USA, Inc 126 
Issue in Honor of Prof Alexander F. Pozharskii ARKIVOC 2009 (iv) 125-135 
acid in boiling benzene for 5 h and subsequent distillation of the reaction mixture gave 2-
(trifluoromethyl)-2H-chromene 4 in 70% yield, which was sensitive to oxygen of air.  
Surprisingly, as in the case of 2-(trifluoromethyl)chroman-4-one 3a, whose isolation and 
characterization had not been reported prior to our work,12 none of these simple compounds was 
recorded in the literature. We regarded these compounds as desirable targets because of their 
relationship to naturally occurring benzopyran derivatives and usefulness as RF-containing 
building blocks for the preparation of more complex partially fluorinated heterocycles.  
 
 
 
Scheme 1. Synthesis of 2-RF-chroman-4-ols 2a–c, 2-RF-chroman-4-ones 3a,b and 2-CF3-2H-
chromene 4.  
 
Application of the Ritter reaction conditions to 2-(polyfluoroalkyl)chroman-4-ols 2a–c gave 
the new compounds 4-acylamino-2-(polyfluoroalkyl)chromans 5a–f. This reaction proceeded 
smoothly for all substrates and analytically pure products can be isolated by simple filtration in 
excellent yields (ca. 95%). The Ritter reaction was stereoselective and chromans 5a–f were 
obtained as mixtures of trans- and cis-isomers (trans/cis = 84/16 – 94/6) without the formation 
of any side products. The determination of the isomers ratio can easily be performed by 1H and 
19F NMR spectroscopic analysis. The hydrolysis of 5a (trans/cis = 92/8) as a representative 
example with concentrated hydrochloric acid led to the pure trans-4-amino-2-
(trifluoromethyl)chroman hydrochloride 6, which was converted into trans-4-benzamido-2-
(trifluoromethyl)chroman 5f under the action of sodium hydroxide and benzoyl chloride 
(Scheme 2).  
The configurations of 5 were assigned from their 1H NMR spectra, in which two sets of 
signals showed the presence of two diastereomers. In the major isomer, JH2a,H3a = 10.8–12.5 Hz 
and JH4e,H3a ≈ JH4e,H3e ≈ 3.7 Hz; in the minor isomer, axial H-3 proton appeared as a quartet with 
JH3a,H3e ≈ JH3a,H4a ≈ JH3a,H2a = 12.0–12.2 Hz. The size of the coupling constants suggests a 2-
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equatorial-4-axial arrangement for the 2 and 4 substituents in the major (trans) isomer and a 
diequatorial arrangement in the minor (cis) isomer. Thus, in this series of chromans, cis-isomer is 
destabilized by repulsion between the 4-equatorial acylamino group and the peri-hydrogen. In 
the 19F NMR spectra of 5a,d–f, the CF3 group of trans- and cis-isomers manifests itself as a 
doublet at 85.2–85.6 and 84.3–84.7 ppm with 3JF,H = 6.6–6.7 and 6.4–6.5 Hz, respectively.  
 
 
 
5 RF R Ratio of trans/cis 5 Yield (%) 
a CF3 Me 92 : 8 95 
b CF2H Me 90 : 10 72 
c C2F5 Me 86 : 14 95 
d CF3 CH2CO2Et 91 : 9 94 
e CF3 CH=CH2 94 : 6 92 
f CF3 Ph 94 : 6 97 
 
Scheme 2. Synthesis of 4-acylamino-2-(polyfluoroalkyl)chromans 5a–f.  
 
This reaction is a simple and effective method for the preparation of protected 4-amino-2-
(polyfluoroalkyl)chromans 5. It should be noted that 4-amino-2,2-dimethyl-6-halogenochromans 
(non-fluorinated analogues of 5) are the key intermediates of the synthetic process, giving, in the 
last step, access to compounds structurally related to the potassium channel opener 
cromakalim.19 These 2,2-dimethylchromans are much more selective for insulin-secreting cells 
over vascular tissue than the reference molecule, cromakalim.19c  
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Conclusions 
 
Reduction of 2-(polyfluoroalkyl)chromones with sodium borohydride and diisobutylaluminium 
hydride provides a simple and convenient preparative procedure from readily available starting 
materials to cis-2-(polyfluoroalkyl)chroman-4-ols and 2-(polyfluoroalkyl)chroman-4-ones, 
which may be considered as new precursors in the synthesis of other highly functionalized 
biologically and medicinally important products. Ritter reaction between cis-2-
(polyfluoroalkyl)chroman-4-ols and nitriles represents a stereoselective approach to the synthesis 
of a variety of trans-4-acylamino-2-(polyfluoroalkyl)chromans and trans-4-amino-2-
(polyfluoroalkyl)chromans.  
 
 
Experimental Section  
 
General Procedures. 1H (400 MHz) and 19F (376 MHz) NMR spectra were recorded on a 
Bruker DRX-400 spectrometer in CDCl3 or DMSO-d6 with TMS and C6F6 as internal standards, 
respectively. IR spectra were recorded on a Perkin-Elmer Spectrum BX-II instrument as KBr 
discs. Elemental analyses were performed at the Microanalysis Services of the Institute of 
Organic Synthesis, Ural Branch, Russian Academy of Sciences. Melting points are uncorrected. 
All solvents used were dried and distilled as per standard procedures. The starting chromones 
1a–c were prepared according to described procedure.20
 
General procedure for the synthesis of cis-2-(polyfluoroalkyl)chroman-4-ols (2a–c) 
Sodium borohydride (285 mg, 7.5 mmol) was added to a cooled (with ice water) solution of 
chromone 1 (5.0 mmol) in 5 ml of methanol. The mixture was stirred at 5–10 oC for 0.5 h and 
diluted with water (10 ml). The colorless crystals that formed were filtered, washed with water, 
dried, and recrystallized from hexane or heptane–ethyl ether (5:1).  
cis-2-(Trifluoromethyl)chroman-4-ol (2a). Yield 83%, mp 127–128 oC. IR (KBr) 3462, 1613, 
1581, 1488, 1462 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.93 (d, 1H, OH, J = 8.4 Hz), 2.03 (ddd, 
1H, H-3a, JH3a,H3e = 12.9 Hz, JH3a,H2a = 12.1 Hz, JH3a,H4a = 10.8 Hz), 2.53 (ddd, 1H, H-3e, JH3e,H3a 
= 12.9 Hz, JH3e,H4a = 6.2 Hz, JH3e,H2a = 2.3 Hz), 4.50 (dqd, 1H, H-2a, JH2a,H3a = 12.1 Hz, JH2a,CF3 = 
6.0 Hz, JH2a,H3e = 2.3 Hz), 5.01 (m, 1H, H-4a), 6.91 (dd, 1H, H-8, J = 8.2, 1.1 Hz), 7.03 (td, 1H, 
H-6, J = 7.5, 1.1 Hz), 7.22 (dddd, 1H, H-7, J = 8.2, 7.3, 1.6 Hz, 6JH7,H4a = 0.7 Hz), 7.49 (dt, 1H, 
H-5, J = 7.7, 1.2 Hz); 19F NMR (376 MHz, CDCl3) δ 82.82 (d, CF3, J = 6.0 Hz). Anal. Calcd for 
C10H9F3O2: C, 55.05; H, 4.16. Found: C, 54.96; H, 4.18.  
cis-2-(Difluoromethyl)chroman-4-ol (2b). Yield 70%, mp 79–80 oC. IR (KBr) 3445, 1613, 
1581, 1487, 1461 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.70 (bs, 1H, OH), 2.05 (dt, 1H, H-3a, 
JH3a,H3e = 13.4 Hz, JH3a,H2a = JH3a,H4a = 9.5 Hz), 2.43 (ddd, 1H, H-3e, JH3e,H3a = 13.4 Hz, JH3e,H4a = 
5.7 Hz, JH3e,H2a = 3.0 Hz), 4.37 (qdd, 1H, H-2a, JH2a,H3a = JH2a,CF2 = 9.9 Hz, JH2a,CHF2 = 4.5 Hz, 
JH2a,H3e = 3.0 Hz), 4.98 (dd, 1H, H-4a, JH4a,H3a = 8.9 Hz, JH4a,H3e = 5.7 Hz), 5.99 (ddd, 1H, CHF2, 
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2JH,F = 55.2, 55.9 Hz, J = 4.5 Hz), 6.88 (dd, 1H, H-8, J = 8.2, 1.2 Hz), 7.00 (td, 1H, H-6, J = 7.5, 
1.2 Hz), 7.22 (dddd, 1H, H-7, J = 8.2, 7.3, 1.7 Hz, 6JH7,H4a = 0.6 Hz), 7.43 (ddd, 1H, H-5, J = 7.8, 
1.7 Hz, 4JH5,H4a = 1.0 Hz); 19F NMR (376 MHz, CDCl3) δ 30.63 (ddd, CFF, 2JF,F = 291.4 Hz, 
2JF,H = 55.2 Hz, 3JF,H = 10.0 Hz), 34.97 (ddd, CFF, 2JF,F = 291.4 Hz, 2JF,H = 55.9 Hz, 3JF,H = 9.8 
Hz). Anal. Calcd for C10H10F2O2: C, 60.00; H, 5.04. Found: C, 59.84; H, 4.90. 
cis-2-(Perfluoroethyl)chroman-4-ol (2c). Yield 65%, mp 120–121 oC. IR (KBr) 3344, 3253, 
1614, 1588, 1489, 1460 cm–1; 1H NMR (400 MHz, CDCl3) δ 1.90 (d, 1H, OH, J = 8.5 Hz), 2.10 
(td, 1H, H-3a, JH3a,H3e = JH3a,H2a = 12.6 Hz, JH3a,H4a = 10.8 Hz), 2.55 (ddt, 1H, H-3e, JH3e,H3a = 
12.8 Hz, JH3e,H4a = 6.2 Hz, JH3e,H2a = JH3e,CFF = 2.0 Hz), 4.62 (dddd, 1H, H-2a, JH2a,CFF = 17.0 Hz, 
JH2a,H3a = 12.0 Hz, JH2a,CFF = 5.0 Hz, JH2a,H3e = 2.0 Hz), 5.04 (dt, 1H, H-4a, JH4a,H3a = 10.0 Hz, 
JH4a,H3e ≈ JH4a,OH = 7.5 Hz), 6.88 (dd, 1H, H-8, J = 8.2, 1.0 Hz), 7.03 (td, 1H, H-6, J = 7.5, 1.0 
Hz), 7.22 (ddd, 1H, H-7, J = 8.3, 7.3, 1.3 Hz), 7.49 (dt, 1H, H-5, J = 7.7, 1.0 Hz). Anal. Calcd for 
C11H9F5O2: C, 49.26; H, 3.38. Found: C, 49.00; H, 3.28.  
2-(Trifluoromethyl)chroman-4-one (3а) from chromanol 2а. Ethyl ether (350 ml) and 
chromanol 2a (35.6 g, 0.163 mol) were placed in a round-bottom flask fitted with a stirrer, 
dropping funnel, and a condenser. The chromic acid solution, prepared from sodium dichromate 
dihydrate (24.4 g, 0.082 mol) and 20.0 ml of concentrated sulfuric acid diluted to 120 ml, was 
added drop-wise to the stirred solution over 1 h, maintaining the temperature at 5–10 oC. The 
reaction mixture was stirred for 4 h at room temperature and allowed to stand overnight. Then 
the upper ether layer was separated, and the aqueous phase extracted with ether (25 ml). The 
combined extracts were washed with a 5% solution of sodium carbonate (2 х 50 ml), then water 
(50 ml), dried over anhydrous calcium chloride, and concentrated to afford the chromanone 3а as 
colorless crystals, 27.8 g (yield 79%), crystallized from hexane, mp 85–86 °C (ref.12: mp 84–85 
оС). IR (KBr) 1704, 1614, 1604, 1578, 1475, 1464 cm–1; 1H NMR (400 MHz, CDCl3) δ 2.92 (dd, 
1H, CHH, J = 16.9, 3.9 Hz), 3.01 (dd, 1H, CHH, J = 16.9, 12.3 Hz), 4.82 (dqd, 1H, CH, J = 12.3, 
5.8, 3.9 Hz), 7.09 (dd, 1H, H-8, J = 8.4, 1.0 Hz), 7.12 (ddd, 1H, H-6, J = 7.9, 7.3, 1.0 Hz), 7.56 
(ddd, 1H, H-7, J = 8.4, 7.3, 1.8 Hz), 7.91 (dd, 1H, H-5, J = 7.9, 1.8 Hz); 19F NMR (376 MHz, 
CDCl3) δ 83.83 (d, CF3, J = 5.8 Hz). Anal. Calcd for C10H7F3O2: C, 55.56; H, 3.26. Found: C, 
55.57; H, 3.12. 
2-(Trifluoromethyl)chroman-4-one (3а) from chromone 1а. To a solution of the chromone 1a 
(1.5 g, 7.0 mmol) in dry tetrahydrofuran (30 ml), a solution of DIBAL in toluene (7.5 mmol) was 
added at –78 оС under a nitrogen atmosphere. After 3 h, the mixture was quenched with water (5 
ml) and allowed to warm to room temperature. After the addition of KOH (3 g in 5 ml of water) 
and ether (30 ml), the organic phase was separated, and the aqueous phase extracted with ether 
(10 ml). The combined extracts were washed with saturated sodium chloride, dried, and 
evaporated to give chromanone 3а as colorless crystals, 850 mg (yield 56%), mp 85–86 оС. 
2-(Difluoromethyl)chroman-4-one (3b). This compound was prepared from chromanol 2b 
analogously to 3a; yield 74% (5.9 g from 8.0 g chromanol 2b), colorless crystals, mp 57–58 °C 
(heptane–ethyl ether). IR (KBr) 1698, 1606, 1577, 1474, 1463 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 2.83 (dd, 1H, CHH, J = 16.9, 3.6 Hz), 2.94 (dd, 1H, CHH, J = 16.9, 12.7 Hz), 4.82 (tdt, 
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1H, CH, J = 12.7, 7.8, 3.5 Hz), 6.04 (ddd, 1H, CHF2, 2JH,F = 55.6, 54.2 Hz, J = 3.3 Hz), 7.04 (dd, 
1H, H-8, J = 8.4, 1.1 Hz), 7.08 (ddd, 1H, H-6, J = 7.9, 7.3, 1.1 Hz), 7.53 (ddd, 1H, H-7, J = 8.4, 
7.3, 1.8 Hz), 7.90 (dd, 1H, H-5, J = 7.9, 1.8 Hz); 19F NMR (376 MHz, CDCl3) δ 29.82 (ddd, 
CFF, 2JF,F = 294.9 Hz, 2JF,H = 55.6 Hz, 3JF,H = 12.7 Hz), 33.26 (ddd, CFF, 2JF,F = 294.9 Hz, 2JF,H 
= 54.2 Hz, 3JF,H = 7.8 Hz). Anal. Calcd for C10H8F2O2: C, 60.61; H, 4.07. Found: C, 60.60; H, 
3.99.  
2-(Trifluoromethyl)-2H-chromene (4). A solution of chromanol 2a (5.5 g, 0.025 mol) in 
benzene (50 ml), along with a catalytic amount of p-toluene sulfonic acid, was refluxed for 5 h 
with a Dean-Stark trap under an atmosphere of nitrogen. After cooling, the reaction mixture was 
washed with a 40% solution of KOH and dried over KOH and the benzene was removed under 
vacuum. Distillation afforded 3.5 g (yield 70%) of chromene 4 as a colorless oil, bp 80–81 оС at 
15 mm. IR (neat) 1650, 1608, 1488, 1459 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.23 (qdd, 1H, H-
2, 3JH,F = 6.6 Hz, J = 3.8, 1.8 Hz), 5.65 (dd, 1H, H-3, J = 10.0, 3.8 Hz), 6.66 (dd, 1H, H-4, J = 
10.0, 1.2 Hz), 6.86 (d, 1H, H-8, J = 8.1 Hz), 6.91 (td, 1H, H-6, J = 7.4, 1.1 Hz), 7.01 (dd, 1H, H-
5, J = 7.5, 1.7 Hz), 7.16 (td, 1H, H-7, J = 7.6, 1.7 Hz); 19F NMR (376 MHz, CDCl3) δ 82.04 (d, 
CF3, J = 6.6 Hz). Anal. Calcd for C10H7F3O: C, 60.01; H, 3.53. Found: C, 59.75; H, 3.32. 
 
General procedure for the synthesis of compounds 5a–c  
A solution of chromanol 2 (1.8 mmol) in 5 ml of acetonitrile, containing 0.3 ml of 98% sulfuric 
acid, was allowed to stand for 1 day at room temperature. Then the reaction mixture was poured 
into cold water (40 ml) and the white precipitate collected by filtration, washed with water and 
dried.  
4-Acetamido-2-(trifluoromethyl)chroman (5a). Yield 95%, mp 181–182 ºС. IR (KBr) 3308, 
1648, 1587, 1527, 1489, 1459 cm–1; 1H NMR (400 MHz, DMSO-d6) trans-isomer (92%) δ 1.86 
(s, 3H, Me), 2.07–2.12 (m, 2H, CH2), 4.80 (dqd, 1H, H-2, J = 12.5, 6.6, 1.5 Hz), 5.07 (dt, 1H, H-
4, J = 7.9, 3.8 Hz), 6.96 (dd, 1H, H-8, J = 8.4, 1.2 Hz), 7.00 (td, 1H, H-6, J = 7.6, 1.2 Hz), 7.23–
7.28 (m, 2H, H-5, H-7), 8.43 (d, 1H, NH, J = 7.9 Hz), cis-isomer (8%) δ 1.83 (q, 1H, CHH, J = 
12.0 Hz), 1.93 (s, 3H, Me), 2.28 (ddd, 1H, CHH, J = 12.5, 6.0, 2.0 Hz), 5.10–5.16 (m, 1H, H-2), 
5.27–5.34 (m, 1H, H-4), 6.89 (dd, 1H, H-8, J = 8.2, 1.2 Hz), 6.99 (m, 1H, H-6), 7.16 (dt, 1H, H-
5, J = 7.7, 1.2), 7.20 (dddd, 1H, H-7, J = 8.2, 7.3, 1.7, 0.9), 8.32 (d, 1H, NH, J = 8.5 Hz); 19F 
NMR (376 MHz, DMSO-d6) trans-isomer (92%) δ 85.51 (d, CF3, 3JH,F = 6.6 Hz), cis-isomer 
(8%) δ 84.61 (d, CF3, 3JH,F = 6.5 Hz). Anal. Calcd for C12H12F3NO2: C, 55.60; H, 4.67; N, 5.40. 
Found: C, 55.44; H, 4.51; N, 5.19. 
4-Acetamido-2-(difluoromethyl)chroman (5b). Yield 72%, mp 164–165 ºС. IR (KBr) 3317, 
1639, 1587, 1533, 1489, 1459 cm–1; 1H NMR (400 MHz, DMSO-d6) trans-isomer (90%) δ 1.84 
(s, 3H, Me), 1.90–2.01 (m, 2H, CH2), 4.41 (qt, 1H, H-2, J = 10.8, 3.5 Hz), 5.01 (dt, 1H, H-4, J = 
7.7, 3.6 Hz), 6.32 (td, 1H, CF2H, 2JH,F = 54.5 Hz, 3JH,H = 3.3 Hz), 6.90 (dd, 1H, H-8, J = 8.2, 1.0 
Hz), 6.95 (td, 1H, H-6, J = 7.5, 1.1 Hz), 7.20–7.25 (m, 2H, H-5, H-7), 8.44 (d, 1H, NH, J = 7.7 
Hz), cis-isomer (10%) δ 1.76 (q, 1H, CHH, J = 12.0 Hz), 1.93 (s, 3H, Me), 2.16 (ddd, 1H, CHH, 
J = 12.7, 5.8, 1.8 Hz), 4.57–4.68 (m, 1H, H-2), 5.19–5.27 (m, 1H, H-4), 6.26 (td, 1H, CF2H, 2JH,F 
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= 54.5 Hz, 3JH,H = 3.2 Hz), 6.84 (dd, 1H, H-8, J = 8.2, 1.1 Hz), 6.94 (td, 1H, H-6, J = 7.6, 1.1 
Hz), 7.12–7.20 (m, 2H, H-5, H-7), 8.29 (d, 1H, NH, J = 8.5 Hz); 19F NMR (376 MHz, DMSO-
d6) trans-isomer (90%) δ 32.56 (dd, CF2H, 2JF,H = 54.5 Hz, 3JF,H = 11.4 Hz), cis-isomer (10%) δ 
31.72 (dd, CF2H, 2JF,H = 54.5 Hz, 3JF,H = 11.4 Hz). Anal. Calcd for C12H13F2NO2: C, 59.75; H, 
5.43; N, 5.81. Found: C, 59.88; H, 5.66; N, 5.80. 
4-Acetamido-2-(perfluoroethyl)chroman (5c). Yield 95%, mp 129–130 ºС. IR (KBr) 3310, 
1650, 1588, 1527, 1489, 1458 cm–1; 1H NMR (400 MHz, DMSO-d6) trans-isomer (86%) δ 1.85 
(s, 3H, Me), 2.05–2.22 (m, 2H, CH2), 4.87–4.97 (m, 1H, H-2), 5.12 (ddd, 1H, H-4, J = 7.7, 4.0, 
2.7 Hz), 6.90 (dd, 1H, H-8, J = 8.3, 1.1 Hz), 7.01 (td, 1H, H-6, J = 7.5, 1.1 Hz), 7.23–7.28 (m, 
2H, H-5, H-7), 8.48 (d, 1H, NH, J = 7.9 Hz), cis-isomer (14%) δ 1.90 (q, 1H, CHH, J = 12.0 
Hz), 1.94 (s, 3H, Me), 2.25–2.31 (m, 1H, CHH), 5.23–5.39 (m, 2H, H-2, H-4), 6.84 (dd, 1H, H-
8, J = 8.2, 1.0 Hz), 6.99 (td, 1H, H-6, J = 7.6, 1.0 Hz), 7.15–7.22 (m, 2H, H-5, H-7), 8.33 (d, 1H, 
NH, J = 8.6 Hz); 19F NMR (376 MHz, DMSO-d6) trans-isomer (86%) δ 33.04 (dd, 1F, CFF, 
2JF,F = 276.6 Hz, 3JF,H = 18.2 Hz), 39.40 (dd, 1F, CFF, 2JF,F = 276.6 Hz, 3JF,H = 5.1 Hz), 81.56 (s, 
3F, CF3), cis-isomer (14%) δ 32.81 (dd, 1F, CFF, 2JF,F = 276.6 Hz, 3JF,H = 17.0 Hz), 39.07 (dd, 
1F, CFF, 2JF,F = 276.6 Hz, 3JF,H = 5.1 Hz), 81.73 (s, 3F, CF3). Anal. Calcd for C13H12F5NO2: C, 
50.49; H, 3.91; N, 4.53. Found: C, 50.59; H, 3.99; N, 4.40. 
4-Carbethoxyacetamido-2-(trifluoromethyl)chroman (5d). This compound was prepared 
from chromanol 2a and ethyl cyanoacetate analogously to 5a–c. Yield 94%, mp 138–139 ºС. IR 
(KBr) 3318, 1736, 1644, 1589, 1524, 1491, 1463 cm–1; 1H NMR (400 MHz, DMSO-d6) trans-
isomer (91%) δ 1.18 (t, 3H, Me, J = 7.1 Hz), 2.08–2.18 (m, 2H, 3-CH2), 3.24 (AB-system, 2H, 
CH2, J = 15.2 Hz), 4.08 (q, 2H, OCH2, J = 7.1 Hz), 4.74–4.83 (m, 1H, H-2), 5.06 (dt, 1H, H-4, J 
= 7.6, 3.8 Hz), 6.97 (d, 1H, H-8, J = 8.2 Hz), 7.02 (td, 1H, H-6, J = 7.5, 1.1 Hz), 7.25–7.30 (m, 
2H, H-5, H-7), 8.71 (d, 1H, NH, J = 7.6 Hz), cis-isomer (9%) δ 1.22 (t, 3H, Me, J = 7.1 Hz), 
1.85 (q, 1H, 3-CHH, J = 12.2 Hz), 2.27–2.34 (m, 1H, 3-CHH), 3.33 (AB-system, 2H, CH2, J = 
15.2 Hz), 4.13 (q, 2H, OCH2, J = 7.1 Hz), 5.10–5.20 (m, 1H, H-2), 5.29–5.37 (m, 1H, H-4), 6.90 
(dd, 1H, H-8, J = 8.2, 1.0 Hz), 6.98 (m, 1H, H-6), 7.19–7.26 (m, 2H, H-5, H-7), 8.62 (d, 1H, NH, 
J = 9.0 Hz); 19F NMR (376 MHz, DMSO-d6) trans-isomer (91%) δ 85.18 (d, CF3, 3JH,F = 6.6 
Hz), cis-isomer (9%) δ 84.29 (d, CF3, 3JH,F = 6.4 Hz). Anal. Calcd for C15H16F3NO4: C, 54.38; H, 
4.87; N, 4.23. Found: C, 54.33; H, 4.54; N, 4.12. 
4-Acrylamido-2-(trifluoromethyl)chroman (5e). This compound was prepared from 
chromanol 2a and acrylonitrile analogously to 5a–c. Yield 92%, mp 180–181 ºС. IR (KBr) 3298, 
1654, 1631, 1587, 1523, 1488, 1458 cm–1; 1H NMR (400 MHz, DMSO-d6) trans-isomer (94%) δ 
2.12–2.21 (m, 2H, CH2), 4.77–4.86 (m, 1H, H-2), 5.17 (dt, 1H, H-4, J = 7.7, 3.6 Hz), 5.66 (dd, 
1H, =CH, J = 8.0, 4.3 Hz), 6.15–6.25 (m, 2H, =CH2), 6.98 (dd, 1H, H-8, J = 8.3, 1.2 Hz), 7.01 
(td, 1H, H-6, J = 7.5, 1.2 Hz), 7.25–7.30 (m, 2H, H-5, H-7), 8.68 (d, 1H, NH, J = 7.7 Hz), cis-
isomer (6%) δ 1.89 (q, 1H, CHH, J = 12.2 Hz), 2.31–2.37 (m, 1H, CHH), 5.14–5.20 (m, 1H, H-
2), 5.37–5.45 (m, 1H, H-4), 5.70 (dd, 1H, =CH, J = 9.8, 2.8 Hz), 6.22–6.32 (m, 2H, =CH2), 6.91 
(dd, 1H, H-8, J = 8.3, 1.0 Hz), 6.98 (m, 1H, H-6), 7.11–7.24 (m, 2H, H-5, H-7), 8.60 (d, 1H, NH, 
J = 8.5 Hz); 19F NMR (376 MHz, DMSO-d6) trans-isomer (94%) δ 85.51 (d, CF3, 3JH,F = 6.6 
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Hz), cis-isomer (6%) δ 84.65 (d, CF3, 3JH,F = 6.5 Hz). Anal. Calcd for C13H12F3NO2: C, 57.57; H, 
4.46; N, 5.16. Found: C, 57.66; H, 4.39; N, 5.09. 
trans-4-Amino-2-(trifluoromethyl)chroman hydrochloride (6). A suspension of amide 5a 
(300 mg, 1.16 mmol) in 36% hydrochloric acid (4 ml) and water (2 ml) was refluxed for 7 h and 
allowed to stand overnight at room temperature. The solid product was collected by filtration, 
washed with ethyl ether and dried to give salt trans-6 as colorless needles, 250 mg (yield 85%), 
mp 240 ºС (subl.). IR (KBr) 3408, 2890, 1613, 1598, 1586, 1515, 1491, 1463 cm–1; 1H NMR 
(400 MHz, DMSO-d6) δ 2.30 (ddd, 1H, CHH, J = 14.8, 12.4, 5.2), 2.54 (dt, 1H, CHH, J = 14.8, 
2.2), 4.62 (bs, 1H, H-4), 5.20 (dqd, 1H, H-2, J = 12.4, 6.4, 2.2), 7.01 (dd, 1H, H-8, J = 8.3, 1.1 
Hz), 7.08 (td, 1H, H-6, J = 7.6, 1.1 Hz), 7.36 (ddd, 1H, H-7, J = 8.3, 7.3, 1.7 Hz), 7.60 (dd, 1H, 
H-5, J = 7.8, 1.7), 8.90 (bs, 3H, N+H3); 19F NMR (376 MHz, DMSO-d6) δ 85.25 (d, CF3, 3JH,F = 
6.4 Hz). Anal. Calcd for C10H11ClF3NO: C, 47.35; H, 4.37; N, 5.52. Found: C, 47.36; H, 4.28; N, 
5.38. 
trans-4-Benzamido-2-(trifluoromethyl)chroman (5f). Hydrochloride 6 (130 mg, 0.5 mmol) 
was treated with 3 ml of 40% aqueous sodium hydroxide and the free base was extracted with 
ether (2 x 5 ml). The combined extracts were evaporated, the residue was dissolved in pyridine 
(2 ml) and benzoyl chloride (360 mg, 2.6 mmol) was added. Then the solution was allowed to 
stand for 1 day at room temperature, poured into 10% hydrochloric acid (10 ml) and the white 
precipitate collected by filtration, washed with water and dried to give trans-5f, 120 mg (yield 
73%), mp >300 оС (decomp.). IR (KBr) 3320, 1630, 1579, 1514, 1487 cm–1; 1H NMR (400 
MHz, DMSO-d6) trans-isomer (100%) δ 2.20–2.25 (m, 2H, CH2), 5.00–5.06 (m, 1H, H-2), 5.37 
(dt, 1H, H-4, J = 7.9, 3.8 Hz), 6.98–7.03 (m, 2H, H-8, H-6) 7.25–7.32 (m, 2H, H-7, H-5), 7.44–
7.49 (m, 2H, H-3´, H-5´), 7.54 (tt, 1H, H-4´, J = 7.3, 1.3 Hz), 7.88–7.92 (m, 2H, H-2´, H-6´), 
8.92 (d, 1H, NH, J = 7.9 Hz). Anal. Calcd for C17H14F3NO2: C, 63.55; H, 4.39; N, 4.36. Found: 
C, 63.21; H, 4.21; N, 4.28. In addition, this compound was prepared as a 94:6 mixture of trans- 
and cis-isomers from chromanol 2a and benzonitrile analogously to 5a–c; 19F NMR (376 MHz, 
DMSO-d6) trans-isomer (94%) δ 85.62 (d, CF3, 3JH,F = 6.7 Hz), cis-isomer (6%) δ 84.66 (d, CF3, 
3JH,F = 6.4 Hz).  
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